| Literature DB >> 25660950 |
Fabienne Meier-Abt1, Mohamed Bentires-Alj2, Christoph Rochlitz3.
Abstract
Pregnancy at early, but not late age, has a strong and life-long protective effect against breast cancer. The expected overall increase in breast cancer incidence demands the development of a pharmaceutical mimicry of early-age pregnancy-mediated protection. Recently, converging results from rodent models and women on molecular and cellular mechanisms underlying the protective effect of early-age pregnancy have opened the door for translational studies on pharmacologic prevention against breast cancer. In particular, alterations in Wnt and TGFβ signaling in mammary stem/progenitor cells reveal new potential targets for preventive interventions, and thus might help to significantly reduce the incidence of breast cancer in the future. ©2015 American Association for Cancer Research.Entities:
Mesh:
Year: 2015 PMID: 25660950 DOI: 10.1158/0008-5472.CAN-14-2717
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701